Skip to main content
Log in

Shared Desmosome Gene Findings in Early and Late Onset Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy

  • Published:
Journal of Cardiovascular Translational Research Aims and scope Submit manuscript

Abstract

Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is an inherited form of cardiomyopathy with low penetrance and variable expressivity. Dominant mutations and rare polymorphisms in desmosome genes are frequently identified. We reasoned that individuals with earlier onset disease would have more frequent desmosome gene mutations and rare polymorphisms. Three groups were compared: Young with symptoms attributable to ARVD/C or a diagnosis of ARVD/C at age of 21 years or earlier, Middle with first symptoms or diagnosis age of 22–49 years, and Late with first symptoms or diagnosis at age of 50 or more years. deoxyribonucleic acid (DNA) sequence analysis was performed on five cardiac desmosome genes, and the presence of mutations and rare missense polymorphisms was compared among the three groups. In the entire Young cohort, 20 (67%) had one or more cardiac desmosome gene mutations. The prevalence of cardiac desmosome gene mutations was similar in the Middle (48%) and Late (53%) cohorts (P = 0.23). Similar numbers of individuals in each cohort had more than one desmosome gene mutation, although the numbers are too small for statistical comparisons. The prevalence of certain rare missense DNA variants was not different among the cohorts (P = 0.71), yet these rare missense alleles were more prevalent in the overall study cohort of 112 ARVD/C participants compared to 100 race-matched controls (P = 0.027). The presence of these variants did not associate with the age of onset of ARVD/C or ventricular tachycardia. These findings highlight the complex interplay of environmental and genetic factors contributing to this condition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Awad, M. M., Calkins, H., & Judge, D. P. (2008). Mechanisms of disease: Molecular genetics of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Nature Clinical Practice. Cardiovascular Medicine, 5, 258–267.

    Article  CAS  PubMed  Google Scholar 

  2. Corrado, D., & Thiene, G. (2006). Arrhythmogenic right ventricular cardiomyopathy/dysplasia: Clinical impact of molecular genetic studies. Circulation, 113, 1634–1637.

    Article  PubMed  Google Scholar 

  3. Dalal, D., Molin, L. H., Piccini, J., Tichnell, C., James, C., Bomma, C., et al. (2006). Clinical features of arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in plakophilin-2. Circulation, 113, 1641–1649.

    Article  CAS  PubMed  Google Scholar 

  4. Gerull, B., Heuser, A., Wichter, T., Paul, M., Basson, C. T., McDermott, D. A., et al. (2004). Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nature Genetics, 36, 1162–1164.

    Article  CAS  PubMed  Google Scholar 

  5. Awad, M. M., Dalal, D., Cho, E., Amat-Alarcon, N., James, C., Tichnell, C., et al. (2006). DSG2 mutations contribute to arrhythmogenic right ventricular dysplasia/cardiomyopathy. American Journal of Human Genetics, 79, 136–142.

    Article  CAS  PubMed  Google Scholar 

  6. Syrris, P., Ward, D., Evans, A., Asimaki, A., Gandjbakhch, E., Sen-Chowdhry, S., et al. (2006). Arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in the desmosomal gene desmocollin-2. American Journal of Human Genetics, 79, 978–984.

    Article  CAS  PubMed  Google Scholar 

  7. Asimaki, A., Syrris, P., Wichter, T., Matthias, P., Saffitz, J. E., & McKenna, W. J. (2007). A novel dominant mutation in plakoglobin causes arrhythmogenic right ventricular cardiomyopathy. American Journal of Human Genetics, 81, 964–973.

    Article  CAS  PubMed  Google Scholar 

  8. McKoy, G., Protonotarios, N., Crosby, A., Tsatsopoulou, A., Anastasakis, A., Coonar, A., et al. (2000). Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet, 355, 2119–2124.

    Article  CAS  PubMed  Google Scholar 

  9. Sen-Chowdhry, S., Syrris, P., & McKenna, W. J. (2005). Genetics of right ventricular cardiomyopathy. Journal of Cardiovascular Electrophysiology, 16, 927–935.

    Article  PubMed  Google Scholar 

  10. Awad, M. M., Dalal, D., Tichnell, C., James, C., Tucker, A., Abraham, T., et al. (2006). Recessive arrhythmogenic right ventricular dysplasia due to novel cryptic splice mutation in PKP2. Human Mutation, 27, 1157.

    Article  PubMed  Google Scholar 

  11. den Haan, A. D., Tan, B. Y., Zikusoka, M. N., Llado, L. I., Jain, R., Daly, A., et al. (2009). Comprehensive desmosome mutation analysis in North Americans with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation: Cardiovascular Genetics, 2, 428–435.

    Article  Google Scholar 

  12. Dalal, D., Nasir, K., Bomma, C., Prakasa, K., Tandri, H., Piccini, J., et al. (2005). Arrhythmogenic right ventricular dysplasia: A United States experience. Circulation, 112, 3823–3832.

    Article  PubMed  Google Scholar 

  13. Taylor, G. P. (2009). The pathology of arrhythmogenic right ventricular cardiomyopathy. In A. R. Redington, G. S. VanArsdell, & R. H. Anderson (Eds.), Congenital diseases in the right heart (pp. 125–129). London: Springer.

    Chapter  Google Scholar 

  14. Dalal, D., James, C., Devanagondi, R., Tichnell, C., Tucker, A., Prakasa, K., et al. (2006). Penetrance of mutations in plakophilin-2 among families with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Journal of the American College of Cardiology, 48, 1416–1424.

    Article  CAS  PubMed  Google Scholar 

  15. Sen-Chowdhry, S., Syrris, P., & McKenna, W. J. (2007). Role of genetic analysis in the management of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Journal of the American College of Cardiology, 50, 1813–1821.

    Article  CAS  PubMed  Google Scholar 

  16. Frigo, G., Bauce, B., Basso, C., & Nava, A. (2006). Late-onset arrhythmogenic right ventricular cardiomyopathy. Journal of Cardiovascular Medicine (Hagerstown), 7, 74–76.

    Article  Google Scholar 

  17. McKenna, W. J., Thiene, G., Nava, A., Fontaliran, F., Blomstrom-Lundqvist, C., Fontaine, G., et al. (1994). Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. British Heart Journal, 71, 215–218.

    Article  CAS  PubMed  Google Scholar 

  18. Christensen, A. H., Benn, M., Tybjaerg-Hansen, A., Haunso, S., & Svendsen, J. H. (2010). Missense variants in plakophilin-2 in arrhythmogenic right ventricular cardiomyopathy patients–disease-causing or innocent bystanders? Cardiology, 115, 148–154.

    Article  CAS  PubMed  Google Scholar 

  19. Posch, M. G., Posch, M. J., Geier, C., Erdmann, B., Mueller, W., Richter, A., et al. (2008). A missense variant in desmoglein-2 predisposes to dilated cardiomyopathy. Molecular Genetics and Metabolism, 95, 74–80.

    Article  CAS  PubMed  Google Scholar 

  20. Nishi, H., Kimura, A., Harada, H., Adachi, K., Koga, Y., Sasazuki, T., et al. (1994). Possible gene dose effect of a mutant cardiac beta-myosin heavy chain gene on the clinical expression of familial hypertrophic cardiomyopathy. Biochemical and Biophysical Research Communications, 200, 549–556.

    Article  CAS  PubMed  Google Scholar 

  21. Ingles, J., Doolan, A., Chiu, C., Seidman, J., Seidman, C., & Semsarian, C. (2005). Compound and double mutations in patients with hypertrophic cardiomyopathy: Implications for genetic testing and counselling. Journal of Medical Genetics, 42, e59.

    Article  CAS  PubMed  Google Scholar 

  22. Morita, H., Rehm, H. L., Menesses, A., McDonough, B., Roberts, A. E., Kucherlapati, R., et al. (2008). Shared genetic causes of cardiac hypertrophy in children and adults. The New England Journal of Medicine, 358, 1899–1908.

    Article  CAS  PubMed  Google Scholar 

  23. Bhuiyan, Z. A., Jongbloed, J. D., van der Smagt, J., Lombardi, P. M., Wiesfeld, A. C., Nelen, M., et al. (2009). Desmoglein-2 and desmocollin-2 mutations in dutch arrhythmogenic right ventricular dysplasia/cardiomypathy patients: Results from a multicenter study. Circulation: Cardiovascular Genetics, 2, 418–427.

    Article  CAS  Google Scholar 

  24. Fressart, V., Duthoit, G., Donal, E., Probst, V., Deharo, J. C., Chevalier, P., et al. (2010). Desmosomal gene analysis in arrhythmogenic right ventricular dysplasia/cardiomyopathy: Spectrum of mutations and clinical impact in practice. Europace, 12, 861–868.

    Article  PubMed  Google Scholar 

  25. Barahona-Dussault, C., Benito, B., Campuzano, O., Iglesias, A., Leung, T. L., Robb, L., et al. (2010). Role of genetic testing in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Clinical Genetics, 77, 37–48.

    Article  CAS  PubMed  Google Scholar 

  26. Basso, C., Thiene, G., Corrado, D., Angelini, A., Nava, A., & Valente, M. (1996). Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis? Circulation, 94, 983–991.

    CAS  PubMed  Google Scholar 

  27. Thiene, G., Nava, A., Corrado, D., Rossi, L., & Pennelli, N. (1988). Right ventricular cardiomyopathy and sudden death in young people. The New England Journal of Medicine, 318, 129–133.

    Article  CAS  PubMed  Google Scholar 

  28. Aronow, W. S., Mercando, A. D., & Epstein, S. (1995). Usefulness of an abnormal signal-averaged electrocardiogram for predicting cardiac death in elderly persons without heart disease. The American Journal of Cardiology, 75, 1273–1274.

    Article  CAS  PubMed  Google Scholar 

  29. Crotti, L., Lundquist, A. L., Insolia, R., Pedrazzini, M., Ferrandi, C., De Ferrari, G. M., et al. (2005). KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome. Circulation, 112, 1251–1258.

    Article  PubMed  Google Scholar 

  30. Xu, T., Yang, Z., Vatta, M., Rampazzo, A., Beffagna, G., Pilichou, K., et al. (2010). Compound and digenic heterozygosity contributes to arrhythmogenic right ventricular cardiomyopathy. Journal of the American College of Cardiology, 55, 587–597.

    Article  CAS  PubMed  Google Scholar 

  31. Marcus, F. I., McKenna, W. J., Sherrill, D., Basso, C., Bauce, B., Bluemke, D. A., et al. (2010). Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: Proposed modification of the task force criteria. Circulation, 121, 1533–1541.

    Article  PubMed  Google Scholar 

  32. Cox, M. G. P. J., van der Smagt, J. J., Noorman, M., Wiesfeld, A. C., Volders, P. G. A., van Langen, I. M., et al. (2010). Arrhythmogenic right ventricular dysplasia/cardiomyopathy diagnostic task force criteria: Impact of new task force criteria. Circulation: Arrhythmia Electrophysiology, 3, 126–133.

    Article  Google Scholar 

Download references

Acknowledgments

This work was supported by funding from the National Institutes of Health (HL088072 to DPJ), the France-Merrick Foundation, JHU Friends in Red, and the Jeff Cooper CARE Foundation. The authors would also like to acknowledge the Johns Hopkins ARVD Program (http://www.arvd.com), which is supported by the Bogle Foundation, the Campanella family, the Wilmerding Endowment, the Dr. Francis P Chiaramonte Foundation, the Healing Hearts Foundation, Boston Scientific, Medtronic, and St Jude Medical. BY Tan was supported by funds from the National Medical Research Council Medical Research Fellowship and the Health Manpower Development Plan Fellowship by the Ministry of Health, Singapore.

Conflicts of Interest

Dr. Hugh Calkins receives honoraria for lectures from Boston Scientific, Medtronic, and St. Jude Medical and is a consultant for Medtronic. The authors have no other potential conflicts of interest to disclose.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daniel P. Judge.

Electronic Supplementary Materials

Below is the link to the electronic supplementary material.

Table S1

Clinical and genetic characteristics of participants. (DOC 42.3 kb)

Fig. S1

Conservation at sites of novel mutations in the Young cohort. Conservation of the mutated amino acid in five novel missense mutations. Amino acids are represented by their standard abbreviations (E Glutamate, K Lysine, G Glycine, T Threonine). ↓ indicates site of mutation. Species are shown by their standard nomenclature. (DOC 41.0 kb)

Fig. S2

Conservation at sites of novel mutations in the Late cohort. Conservation of the mutated amino acid in three novel missense mutations. Amino acids are represented by their standard abbreviations (D aspartate, E glutamate, V valine). ↓ indicates site of mutation. Species are shown by their standard nomenclature. (DOC 31.5 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tan, B.Y., Jain, R., den Haan, A.D. et al. Shared Desmosome Gene Findings in Early and Late Onset Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy. J. of Cardiovasc. Trans. Res. 3, 663–673 (2010). https://doi.org/10.1007/s12265-010-9224-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12265-010-9224-4

Keywords

Navigation